Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-04

Clinical Trial Update: Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis [NA]

View source ↗

Summary

A clinical trial comparing Qingkailing Injection to Puerarin Injection examines withdrawal rates from corticosteroids in patients with active rheumatoid arthrit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Puerarin Injection
  • Qingkailing Injection

Snippet

Sponsor: Chengdu PLA General Hospital | Conditions: Rheumatoid Arthritis | NA | Status: UNKNOWN